To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·02-14 07:13
      ARKG Investment Tracker position change: Increased position in Veeva by 1,056 shares, the number of shares held increased 2.55% compared to the previous period and now represents 0.61% of the total position.
      80Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·02-14 07:13
      ARKG Investment Tracker position change: Increased position in Veracyte by 28,842 shares, the number of shares held increased 2.6% compared to the previous period and now represents 3.3% of the total position.
      102Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·02-14 07:13
      ARKG Investment Tracker position change: Increased position in Intellia Therapeutics by 78,716 shares, the number of shares held increased 2.6% compared to the previous period and now represents 3% of the total position.
      2Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·02-14 07:13
      ARKG Investment Tracker position change: Increased position in Incyte by 3,564 shares, the number of shares held increased 2.59% compared to the previous period and now represents 1.12% of the total position.
      8Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·02-14 07:13
      ARKG Investment Tracker position change: Increased position in Atai Beckley Inc by 86,724 shares, the number of shares held increased 2.6% compared to the previous period and now represents 1.09% of the total position.
      2Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·02-14 07:13
      ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 682 shares, the number of shares held increased 2.6% compared to the previous period and now represents 1% of the total position.
      14Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·02-14 07:13
      ARKG Investment Tracker position change: Increased position in Tempus AI by 50,247 shares, the number of shares held increased 2.66% compared to the previous period and now represents 8.38% of the total position.
      10Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·02-14 07:13
      ARKG Investment Tracker position change: Increased position in Nurix Therapeutics by 41,844 shares, the number of shares held increased 2.6% compared to the previous period and now represents 2.14% of the total position.
      13Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·02-14 07:13
      ARKG Investment Tracker position change: Increased position in Prime Medicine, Inc. by 131,032 shares, the number of shares held increased 2.6% compared to the previous period and now represents 1.44% of the total position.
      29Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·02-14 07:13
      ARKG Investment Tracker position change: Increased position in Ionis Pharmaceuticals by 10,560 shares, the number of shares held increased 2.6% compared to the previous period and now represents 2.83% of the total position.
      1Comment
      Report
    • empty
      No following yet
       
       
       
       

      Most Discussed